Master Class: Testicular Cancer 2026 - Precision, Pragmatism, and the Long Game

Friday, November 13, 2026

10:30 - 12:00 CET

Co-Chair(s)

AB

Aditya Bagrodia

Professor
University of California San Diego, United States
Karima Oualla

Associate Professor of Medical Oncology
Hassan II University Hospital, Morocco

At the end of this session, attendees should be able to:

Apply contemporary, guideline-directed management strategies for patients with germ cell tumors (GCTs), including recent updates that influence staging, treatment selection, and follow-up.
Critically evaluate de-escalation strategies in Stage I seminoma and NSGCT, balancing oncologic outcomes with psychosocial, fertility, and quality-of-life considerations using shared decision-making frameworks.
Assess the current and emerging role of biomarkers, including miRNA-371 and circulating tumor DNA (ctDNA), in diagnosis, surveillance, and risk-adapted treatment of testicular cancer.
Select optimal surgical and multimodal management approaches for Stage II disease and advanced GCTs, including indications, benefits, and limitations of primary, robotic, and post-chemotherapy RPLND, with an emphasis on long-term survivorship.

10:30 - 10:38 CET

Guideline-directed Care of Patients with Gcts: What’s New?
10:38 - 10:46 CET

Stage I Seminoma and NSGCT: How Little Is Enough? – Christian Fankhauser (Switzerland) – 8 mins 1. key focus: 1. surveillance vs Adjuvant therapy 2. psychosocial and Fertility outcomes 3. shared Decision-making Frameworks
10:46 - 10:54 CET

Biomarkers that matter: miRNA-371 and ctDNA ?
Speaker: Clint Cary
10:54 - 11:02 CET

Stage II Seminoma: Modern Algorithms
Speaker: Aditya Bagrodia – University of California San Diego
11:02 - 11:10 CET

Primary RPLND for Marker-positive NSGCT: Ready for Prime Time?
11:10 - 11:18 CET

Robotic RPLND: Progress and Pitfalls
Speaker: Vitaly Margulis
11:18 - 11:26 CET

Survivorship Is the Endpoint: Long-term Toxicity, Fertility, and Quality of Life
Speaker: Karima Oualla – Hassan II University Hospital
11:26 - 11:34 CET

Optimal Approach to Post-chemotherapy RPLND
Speaker: Axel Heidenreich – University Hospital Cologne
11:34 - 12:00 CET

Case-based management of GCTs
Moderator: Gagan Prakash – Tata Memorial Hospital, Homi Bhabha National Institute
Panelist: Ofer Yossepowitch – Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel
Panelist: Muhannad Alsyouf